Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cartesian Therapeutics (RNAC) Change in Taxes (2021 - 2022)

Historic Change in Taxes for Cartesian Therapeutics (RNAC) over the last 2 years, with Q3 2022 value amounting to -$321000.0.

  • Cartesian Therapeutics' Change in Taxes fell 10202.81% to -$321000.0 in Q3 2022 from the same period last year, while for Jun 2023 it was -$321000.0, marking a year-over-year decrease of 20000.0%. This contributed to the annual value of -$601000.0 for FY2022, which is 20000.0% down from last year.
  • Per Cartesian Therapeutics' latest filing, its Change in Taxes stood at -$321000.0 for Q3 2022, which was down 10202.81% from $1000.0 recorded in Q2 2022.
  • In the past 5 years, Cartesian Therapeutics' Change in Taxes registered a high of $15.8 million during Q3 2021, and its lowest value of -$15.2 million during Q4 2021.